Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T15:57:09.132Z.
Calculation as of: 2026-10-06T15:57:09.132Z.
Quote observation: 2026-10-06T15:55:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85bde4aa0a662304b106d2bd805683c4a4a85ed0eecab472c1d88190f6ac555e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-08-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.46B
Price/OCF Ratio
9.27
TTM Avg
9.60
3Y Avg
21.94
5Y Avg
276.98
Market Cap
$1.44B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.49B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.44B
Price/OCF Ratio
79.37
TTM Avg
254.68
3Y Avg
254.68
5Y Avg
167.20
Market Cap
$1.50B
Price/OCF Ratio
21.79
TTM Avg
21.79
3Y Avg
15.72
5Y Avg
18.04
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | $1.46B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 9.27 | 9.60 | 21.94 | 276.98 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.48B | 17.89 | 12.61 | 22.38 | 32.95 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | N/A | N/A | N/A | N/A |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 79.37 | 254.68 | 254.68 | 167.20 |
| GH Research PLC (GHRS)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 21.79 | 21.79 | 15.72 | 18.04 |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 26.60 | 22.09 | 27.32 | 28.27 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2025-08-12 | 8.61 |
| 2025-08-11 | 8.44 |
| 2025-08-08 | 8.24 |
| 2025-08-07 | 8.35 |
| 2025-08-06 | 8.93 |
| 2025-08-05 | 9.09 |
| 2025-08-04 | 9.56 |
| 2025-08-01 | 9.34 |
| 2025-07-31 | 9.25 |
| 2025-07-30 | 9.72 |
| 2025-07-29 | 9.87 |
| 2025-07-28 | 10.25 |
| 2025-07-25 | 10.54 |
| 2025-07-24 | 10.31 |
| 2025-07-23 | 11.06 |
| 2025-07-22 | 10.62 |
| 2025-07-21 | 10.44 |
| 2025-07-18 | 11.14 |
| 2025-07-17 | 10.69 |
| 2025-07-16 | 10.19 |
| 2025-07-15 | 10.03 |
| 2025-07-14 | 9.87 |
| 2025-07-11 | 9.43 |
| 2025-07-10 | 9.80 |
| 2025-07-09 | 9.45 |
| 2025-07-08 | 9.44 |
| 2025-07-07 | 7.60 |
| 2025-07-03 | 7.21 |
| 2025-07-02 | 7.43 |
| 2025-07-01 | 7.31 |
| 2025-06-30 | 7.69 |
| 2025-06-27 | 7.60 |
| 2025-06-26 | 7.99 |
| 2025-06-25 | 7.15 |
| 2025-06-24 | 6.47 |
| 2025-06-23 | 6.73 |
| 2025-06-20 | 7.01 |
| 2025-06-18 | 7.06 |
| 2025-06-17 | 7.77 |
| 2025-06-16 | 8.34 |
| 2025-06-13 | 8.40 |
| 2025-06-12 | 8.49 |
| 2025-06-11 | 8.01 |
| 2025-06-10 | 8.07 |
| 2025-06-09 | 8.03 |
| 2025-06-06 | 8.10 |
| 2025-06-05 | 8.36 |
| 2025-06-04 | 8.69 |
| 2025-06-03 | 8.56 |
| 2025-06-02 | 7.58 |
| 2025-05-30 | 6.27 |
| 2025-05-29 | 7.63 |
| 2025-05-28 | 7.20 |
| 2025-05-27 | 7.02 |
| 2025-05-23 | 6.44 |
| 2025-05-22 | 6.37 |
| 2025-05-21 | 6.59 |
| 2025-05-20 | 6.34 |
| 2025-05-19 | 6.08 |
| 2025-05-16 | 5.80 |
| 2025-05-15 | 5.80 |
| 2025-05-14 | 5.22 |
| 2025-05-13 | 5.69 |
| 2025-05-12 | 5.84 |
| 2025-05-09 | 5.55 |
| 2025-05-08 | 5.78 |
| 2025-05-07 | 5.47 |
| 2025-05-06 | 5.25 |
| 2025-05-05 | 6.01 |
| 2025-05-02 | 6.26 |
| 2025-05-01 | 6.11 |
| 2025-04-30 | 5.33 |
| 2025-04-29 | 5.07 |
| 2025-04-28 | 4.83 |
| 2025-04-25 | 4.73 |
| 2025-04-24 | 4.44 |
| 2025-04-23 | 5.51 |
| 2025-04-22 | 5.69 |
| 2025-04-21 | 5.26 |
| 2025-04-17 | 4.85 |
| 2025-04-16 | 4.72 |
| 2025-04-15 | 4.67 |
| 2025-04-14 | 4.90 |
| 2025-04-11 | 4.51 |
| 2025-04-10 | 4.38 |
| 2025-04-09 | 4.60 |
| 2025-04-08 | 4.36 |
| 2025-04-07 | 5.14 |
| 2025-04-04 | 5.23 |
| 2025-04-03 | 5.37 |
| 2025-04-02 | 5.98 |
| 2025-04-01 | 5.71 |
| 2025-03-31 | 6.20 |
| 2025-03-28 | 6.43 |
| 2025-03-27 | 6.34 |
| 2025-03-26 | 6.06 |
| 2025-03-25 | 6.55 |
| 2025-03-24 | 6.68 |
| 2025-03-21 | 6.27 |
| 2025-03-20 | 6.73 |
| 2025-03-19 | 6.83 |
| 2025-03-18 | 6.79 |
| 2025-03-17 | 6.47 |
| 2025-03-14 | 6.19 |
| 2025-03-13 | 6.36 |
| 2025-03-12 | 6.36 |
| 2025-03-11 | 6.32 |
| 2025-03-10 | 6.63 |
| 2025-03-07 | 6.76 |
| 2025-03-06 | 6.60 |
| 2025-03-05 | 6.68 |
| 2025-03-04 | 6.67 |
| 2025-03-03 | 6.22 |
| 2025-02-28 | 6.88 |
| 2025-02-27 | 7.16 |
| 2025-02-26 | 6.59 |
| 2025-02-25 | 5.95 |
| 2025-02-24 | 6.09 |
| 2025-02-21 | 6.81 |
| 2025-02-20 | 6.85 |
| 2025-02-19 | 7.07 |
| 2025-02-18 | 7.20 |
| 2025-02-14 | 6.76 |
| 2025-02-13 | 6.37 |
| 2025-02-12 | 6.74 |
| 2025-02-11 | 7.02 |
| 2025-02-10 | 7.30 |
| 2025-02-07 | 7.53 |
| 2025-02-06 | 7.32 |
| 2025-02-05 | 7.22 |
| 2025-02-04 | 7.46 |
| 2025-02-03 | 8.44 |
| 2025-01-31 | 8.98 |
